GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare ...

As WVU Medicine has grown from seven hospitals to 25 in the last six years, Todd Karpinski, PharmD, vice president and chief pharmacy officer, said the health system has found itself confronting the ...

When big infrastructure projects spring up, one crucial law — the National Environmental Policy Act — has for decades been a ...

Industry Veteran and Former Pfizer Chief Scientific Officer Brings Extensive R&D and Leadership Experience to Advance BenchSci's Mission of Improving the Speed and Quality of Preclinical R&D ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is one of the Stocks With Huge Catalysts on the Horizon. On July 25, KalVista ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Aligned with AI Action Plan healthcare priorities, Tevogen.AI has recently developed the alpha version of PredicTcell™, a proprietary machine learning model built in collaboration with Microsoft ...

Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...

HealthDay News — Artificial intelligence (AI) support improves radiologists’ breast cancer detection accuracy when reading mammograms, according to a study published online July 8 in Radiology.

Europe has given limited approval to Lilly's Alzheimer's drug, President Trump has announced a trade deal with the EU, Delta ...